The expression of Dab2 has found to be decreased in several cancers [8], [9] including ovarian cancer, prostate cancer, etc. Conversely, ectopic expression of Dab2 inhibits the growth of prostate cancer, and choriocarcinoma cell lines [10], [11]. Here, DAB2 is linked to ovarian carcinoma.